Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Doctorant·e : Guillaume Charbonnier
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
55
55 articles ont été cités au moins 55fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
9 485
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
238
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
129
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Centre Hospitalier Universitaire de Besançon
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial
2025ArticleJournal of Neurosurgery
Silk Vista Baby for the treatment of distal anterior cerebral artery aneurysms
2025ArticleNeuroradiology
Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study
2023ArticleInterventional Neuroradiology
Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations
2023ArticleWorld Neurosurgery
Successful Thrombectomy Improves Functional Outcome in Tandem Occlusions with a Large Ischemic Core
2023ArticleWorld Neurosurgery
CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): 12-month angiographic results of a multicenter study
2023ArticleJournal of Neurointerventional Surgery
Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
2022ArticleJournal of Neurosurgery
Surgical treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
2022ArticleJournal of Neurosurgery
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of neurointerventional surgery · 2019
Background and purpose Flow diversion is an innovative and increasingly used endovascular treatment for intracranial aneurysms. Its initial evaluation with the first devices available showed good efficacy of this treatment with variable safety results. The Flow Direction Endoluminal Device (FRED) has a specific design and was evaluated in a single-arm, multicenter, prospective, Good Clinical Practice study: SAFE (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment). This analysis reports clinical results at 1 year and anatomical results at 6 months and 1 year. Methods Patients with unruptured and recanalized aneurysms located in the anterior circulation treated with FRED and FRED Jr were prospectively included. A Clinical Event Committee and a Core Laboratory independently evaluated clinical outcome and anatomical results. Results Thirteen interventional neuroradiology centers included 103 patients/aneurysms. Aneurysm locations were supraclinoid internal carotid artery (ICA) in 71 (68.9%), cavernous ICA in 15 (14.6%), anterior cerebral or anterior communicating artery in 9 (8.7%), and middle cerebral artery in 8 (7.8%). Most aneurysms were small (<10 mm) in 71 patients (68.9%). Cumulative 1-year mortality and morbidity rates were 2/103 (1.9%) and 3/103 (2.9%), respectively, one death being related to cancer. At 1 year, anatomical results were: complete occlusion in 66/90 patients (73.3%), neck remnant in 7/90 patients (7.8%), and aneurysm remnant in 17/90 patients (18.9%). Conclusions SAFE study analysis at 1 year confirms the excellent safety profile of the FRED device for aneurysm treatment, with low morbidity and mortality rates (2.9% and 1.9%, respectively) and demonstrates its efficacy (adequate occlusion in 73/90 (81.1%)). Clinical trial registration Unique identifier: NCT02921698; Results.
Stroke · 2019
Background and Purpose— Emergent carotid artery stenting plus mechanical thrombectomy is an effective treatment for acute ischemic stroke patients with tandem occlusion of the anterior circulation. However, there is limited data supporting the safety of this approach in patients treated with prior intravenous thrombolysis (IVT). We aimed to investigate the safety of emergent carotid artery stenting-mechanical thrombectomy approach in stroke patient population treated with prior IVT. Methods— We assessed patients with acute ischemic stroke because of atherosclerotic tandem occlusion that were treated with emergent carotid artery stenting-mechanical thrombectomy approach from the multicenter observational Thrombectomy in Tandem Lesions registry. Patients were divided into 2 groups based on pretreatment IVT (IVT versus no-IVT). Intracerebral hemorrhages were classified according to the European Cooperative Acute Stroke Study II criteria. Results— Among 205 patients included in the present study, 125 (60%) received prior IVT. Time from symptoms onset-to-groin puncture was shorter (234±100 versus 256±234 minutes; P =0.002), and heparin use was less in the IVT group (14% versus 35%; P <0.001); otherwise, there was no difference in the baseline characteristics. There was no significant difference between the IVT and no-IVT groups in the rate of symptomatic intracerebral hemorrhage (5% versus 8%; P =0.544), parenchymal hematoma type 1 to 2 (15% versus 18%; P =0.647), successful reperfusion (modified Thrombolysis in Cerebral Ischemia 2b–3), or 90-day favorable outcome (modified Rankin Scale score of 0–2 at 90 days). The 90-day all-cause mortality rate was significantly lower in the IVT group (8% versus 20%; P =0.017). After adjusting for covariates, IVT was not associated with symptomatic intracerebral hemorrhage or 90-day mortality. Conclusions— Emergent carotid artery stenting-mechanical thrombectomy approach was not associated with an increased risk of hemorrhagic complications in tandem occlusion patients who received IVT before the intervention.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Chinese neurosurgical journal · 2026 · Journal Article
Moubark M, Biondi A, Othman M, Findler M, et al.
Neuroradiology · 2025 · Published Erratum
Scarcia L, Clarençon F, Dmytriw AA, Shotar E, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025 · Journal Article
Janot K, Charbonnier G, Marnat G, Sporns P, et al.
Neuroradiology · 2025 · Journal Article
Scarcia L, Clarençon F, Dmytriw AA, Shotar E, et al.
Journal of neurointerventional surgery · 2024 · Journal Article
Guetarni Z, Bernard R, Boulouis G, Labeyrie MA, et al.
Journal of neuroradiology = Journal de neuroradiologie · 2024 · Letter
Charbonnier G, Di Caterino F, Biondi A
Digital health · 2024 · Journal Article
Charbonnier G, Consoli A, Bonnet L, Biondi A, et al.
Journal of neurointerventional surgery · 2024 · Video-Audio Media
Biondi A, Primikiris P, Di Caterino F, Vancheri S, et al.
Journal of neuroradiology = Journal de neuroradiologie · 2024 · Journal Article
Charbonnier G, Primikiris P, Desmarets M, Tio G, et al.
Journal of neurointerventional surgery · 2023 · Journal Article
Biondi A, Primikiris P, Vitale G, Charbonnier G
Journal of neurointerventional surgery · 2023 · Multicenter Study
Spelle L, Herbreteau D, Caroff J, Barreau X, et al.
World neurosurgery · 2023 · Randomized Controlled Trial
Raymond J, Benomar A, Gentric JC, Magro E, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022 · Journal Article
Power S, Biondi A, Saatci I, Bennett K, et al.
Journal of clinical medicine · 2022 · Journal Article
Charbonnier G, Primikiris P, Billottet B, Louvrier A, et al.
Frontiers in neurology · 2022 · Journal Article
Dillmann M, Bonnet L, Vuillier F, Moulin T, et al.
Stroke · 2021 · Journal Article
Cagnazzo F, Piotin M, Escalard S, Maier B, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2021 · Journal Article
Dahl RH, Biondi A, Caterino FD, Vitale G, et al.
Frontiers in medicine · 2021 · Journal Article
Marino A, Cimaz R, Pelagatti MA, Tattesi G, et al.
Frontiers in neurology · 2020 · Journal Article
Charbonnier G, Bonnet L, Biondi A, Moulin T
Stroke · 2020 · Journal Article
Zhu F, Anadani M, Labreuche J, Spiotta A, et al.
Interventional neurology · 2020 · Journal Article
Haussen DC, Turjman F, Piotin M, Labreuche J, et al.
Cerebrovascular diseases extra · 2020 · Comparative Study
Charbonnier G, Bonnet L, Bouamra B, Vuillier F, et al.
Neuroradiology · 2019 · Editorial
Goyal M, Almekhlafi MA, Cognard C, McTaggart R, et al.
World neurosurgery · 2026 · Journal Article
Alhazmi H, Darsaut TE, Gentric JC, Roy D, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Griessenauer CJ, Ghozy S, Biondi A, Hecker C, et al.
Journal of neurosurgery · 2025 · Journal Article
Darsaut TE, Gentric JC, Heppner J, Lopez C, et al.
The Lancet. Neurology · 2026 · Journal Article
Gory B, Maïer B, Pop R, Wolff V, et al.
AJNR. American journal of neuroradiology · 2026 · Journal Article
Boisseau W, Combaz X, Levrier O, Smajda S, et al.
International journal of stroke : official journal of the International Stroke Society · 2021 · Clinical Trial Protocol
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026 · Journal Article
Salim HA, Scarcia L, Clarençon F, Hajjeh O, et al.
The Lancet. Neurology · 2026 · Journal Article
Gory B, Maïer B, Pop R, Wolff V, et al.
Journal of neurointerventional surgery · 2022 · Journal Article
Spelle L, Herbreteau D, Caroff J, Barreau X, et al.
Expert review of medical devices · 2021 · Journal Article
Primikiris P, Hadjigeorgiou G, Tsamopoulou M, Biondi A, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2020 · Case Reports
Di Caterino F, Primikiris P, Vitale G, Biondi A
Expert review of medical devices · 2019 · Journal Article
Iosif C, Biondi A
Frontiers in immunology · 2021 · Case Reports
Saettini F, Fazio G, Moratto D, Galbiati M, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2020 · Case Reports
Di Caterino F, Primikiris P, Vitale G, Biondi A
Frontiers in endocrinology · 2024 · Journal Article
Molinari S, Fossati C, Nicolosi ML, Di Marco S, et al.
Frontiers in pediatrics · 2021 · Journal Article
Nicastro E, Verdoni L, Bettini LR, Zuin G, et al.
The Lancet. Rheumatology · 2021 · Journal Article
Civino A, Alighieri G, Prete E, Caroleo AM, et al.
Acta paediatrica (Oslo, Norway : 1992) · 2021 · Journal Article
Saettini F, Cattoni A, Redaelli M, Silvestri D, et al.
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Abstract Background Cell cycle regulators have gain attention as potential targets for anticancer therapy. Palbociclib is a selective inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6), which coordinate the G1-S
Additional file 1: of The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were treated with increasing concentrations of the indicated PI3K/mTOR inhibitors. After 72h cell proliferation was evaluated
Additional file 1: of The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were treated with increasing concentrations of the indicated PI3K/mTOR inhibitors. After 72h cell proliferation was evaluated
Influence of motor and cognitive tasks on time estimation
The folder<strong> "DataTapisTime" </strong>contains <strong>thirty-two .MAT files.</strong> The .mat files’ name includes the number of subject (“SXX”, from S01 to S16) and the condition (Sitting or Walking). Each matri
Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study
BackgroundThe occurrence of persistent intra-device filling (BOSS 1, using the Bicêtre Occlusion Scale Score (BOSS)) in aneurysms treated with a Woven Endobridge (WEB) device is infrequent based on angiographic follow-up
Additional file 2: of The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Figure S1. A sequential exposure to palbociclib followed by PI3K/AKT/mTOR inhibitors alone induces additive effects. MDA-MB-231 were pre-incubated with 0.5 ÎźM palbociclib for 24h and then treated with increasing concent
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Journal of neurointerventional surgery · 2025 · Journal Article
Scarcia L, Clarençon F, Dmytriw AA, Shotar E, et al.
Stroke · 2022 · Clinical Trial
Zaidat OO, Fifi JT, Nanda A, Atchie B, et al.
Journal of neurointerventional surgery · 2022 · Journal Article
Shotar E, Labeyrie MA, Biondi A, Velasco S, et al.
Stroke · 2019 · Journal Article
Gory B, Berge J, Bonafé A, Pierot L, et al.
Cardiovascular and interventional radiology · 2019 · Journal Article
Zhu F, Piotin M, Steglich-Arnholm H, Labreuche J, et al.
Stroke · 2019 · Journal Article
Anadani M, Spiotta AM, Alawieh A, Turjman F, et al.
Journal of neurointerventional surgery · 2019 · Journal Article
Anadani M, Spiotta A, Alawieh A, Turjman F, et al.
Zhu F, Hossu G, Soudant M, Richard S, et al.
BMJ open · 2021 · Clinical Trial Protocol
Riou-Comte N, Zhu F, Cherifi A, Richard S, et al.
The Lancet. Neurology · 2020 · Journal Article
Mohr JP, Overbey JR, Hartmann A, Kummer RV, et al.
Journal of neurointerventional surgery · 2019 · Journal Article
Pierot L, Spelle L, Berge J, Januel AC, et al.
Journal of neurointerventional surgery · 2019 · Journal Article
Martínez-Galdámez M, Biondi A, Kalousek V, Pereira VM, et al.